Search results
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 4 days agoA Food and Drug Administration expert panel voted Wednesday to manufacture new COVID-19 vaccines to...
FDA panel recommends new COVID-19 vaccine formula for fall
United Press International via Yahoo News· 2 days agoA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for...
Doctor who claimed COVID-19 vaccines made people magnetic being sued by IRS
CBS News· 5 days agoAn Ohio doctor who drew national attention when she claimed COVID-19 vaccines made people magnetic...
Study: Deaths remained elevated, even after COVID-19 vaccine
Arizona Daily Sun· 4 days agoMore people than expected died in Western nations for three consecutive years amid the COVID-19...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
WSAU Wausau· 3 days ago(Reuters) - COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots...
Alarming Findings: COVID-19 Triggers Lethal Lung Disease in Previously Unaffected Populations
SciTechDaily· 5 hours agoResearchers discovered that during the COVID-19 pandemic, there was a surge in a rare autoimmune...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 1 day agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CBS 58 Milwaukee· 24 hours agoThe FDA told the advisory committee Wednesday that studies have shown that the currently available Covid-19 vaccines appear to be less ...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 6 days ago...In the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
FDA Advises Covid-19 Vaccine Makers to Tackle JN.1 Variant
Morningstar· 1 day agoBy Sabela Ojea The Food and Drug Administration has recommended that manufacturers of Covid-19 vaccines should focus on the JN.1 variant ...